4:11 PM · 28 March 2024

نظرة على مخطط - US500 (28.03.2024)

يقترب الربع الأول من عام 2024 من نهايته، وكانت فترة قوية لسوق الأسهم الأمريكية. ارتفع مؤشر S&P 500 بنسبة 9٪ تقريبًا خلال هذا الوقت. غالبًا ما يؤدي هذا النمو الكبير إلى إعادة توازن المحفظة من خلال الصناديق للحفاظ على توزيع الأصول المرغوب فيه. وتشير تقديرات بنك جولدمان ساكس إلى أن صناديق التقاعد قد تضطر إلى بيع ما يصل إلى 32 مليار دولار من الأسهم، مما قد يفرض ضغوطًا هبوطية على الأسواق والمؤشر نفسه. وكان أحدث مثال على إعادة التوازن هذه في يوليو/تموز 2023، بين الربعين الثاني والثالث. خلال تلك الفترة، شهد عقد US500 انخفاضًا بنسبة 2٪ تقريبًا.

 

المصدر: Xsatation5

Milad Azar

Market Research Analyst • UAE

Senior Market analyst with XTB for more than three years, specializing in global financial market, macroeconomic analysis, technical analysis with a strong focus on Asian market

I hold a master of science degree in Financial Risk management 
regular commentator on CNBC arabia, Skynews and TRT world

Go to the expert 
24 July 2026, 9:55 PM

Daily Summary: Equities Diverge as Tech Lags, Europe Rallies on Earnings & PMIs (24.07.2026)

24 July 2026, 8:43 PM

Three markets to watch next week (24.07.2026)

24 July 2026, 6:22 PM

US OPEN: Nasdaq hits 1-month low! Geopolitics bring AI trade down!

24 July 2026, 3:37 PM

Market Wrap: European Stocks Are Trying to Rebound as the Week Comes to an End💡

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.